WYNVIAN (U.S. Trademark Serial Number 88410726) is a United States trademark of Athenex, Inc.. The goods and services include: Pharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Pharmaceutical preparations and drugs for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in the treatment of skin disorders, skin aliments and skin conditions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue . The correspondent is Anne F. Downey of HARTER SECREST & EMERY LLP.
This trademark was filed on May 01, 2019 as United States Trademark Application Serial Number 88410726. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED
November 13, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
November 11, 2021 – SOU EXTENSION 4 GRANTED
November 11, 2021 – SOU EXTENSION 4 FILED
November 11, 2021 – TEAS EXTENSION RECEIVED
June 01, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 28, 2021 – SOU EXTENSION 3 GRANTED
May 28, 2021 – SOU EXTENSION 3 FILED
View full trademark status information at USPTO
Ownership History
Athenex, Inc.
Athenex, Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.